Indian Journal of Obstetrics and Gynecology Research
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN: 2394-2746
Online ISSN: 2394-2754
CODEN : IJOGCS
Indian Journal of Obstetrics and Gynecology Research (IJOGR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...Case Report
Author Details :
Volume : 5, Issue : 1, Year : 2018
Article Page : 154-156
https://doi.org/10.18231/2394-2754.2018.0034
Abstract
Ovarian fibroma comprises 3% of all ovarian neoplasms and their malignant counterpart is very rare. Till today only 100 cases have been reported in the literature.1 Woman aged 60 years, postmenopausal, reported with pain in abdomen from 3 years. A 10 x 6 cm mobile, firm ovarian mass was felt through left fornix with no other significant findings was noted in general and systemic examination. All tumor markers were within normal limit. USG detected left ovarian mass. Laparotomy showed white, firm, solid mass arising from left ovary of 10x7cm size. No evidence of metastases. Histopathology examination revealed ovarian fibrosarcoma.
Keywords: Fibrosarcoma ovary, Ovarian malignancy.
How to cite : Ali H, Swami M B, A rare case of fibrosarcoma of ovary. Indian J Obstet Gynecol Res 2018;5(1):154-156
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
